MA37872A1 - Benzothiazolone compound salts used as a beta-2-adrenoceptor agonist - Google Patents
Benzothiazolone compound salts used as a beta-2-adrenoceptor agonistInfo
- Publication number
- MA37872A1 MA37872A1 MA37872A MA37872A MA37872A1 MA 37872 A1 MA37872 A1 MA 37872A1 MA 37872 A MA37872 A MA 37872A MA 37872 A MA37872 A MA 37872A MA 37872 A1 MA37872 A1 MA 37872A1
- Authority
- MA
- Morocco
- Prior art keywords
- beta
- salts used
- adrenoceptor agonist
- compound salts
- benzothiazolone compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne un composé de formule (i) sous forme de sel acétate (i), un procédé de fabrication du composé de l'invention et ses utilisations thérapeutiques. La présente invention concerne de plus une combinaison de principes pharmacologiquement actifs et des compositions pharmaceutiques.The present invention relates to a compound of formula (i) in acetate salt form (i), a process for producing the compound of the invention and its therapeutic uses. The present invention further relates to a combination of pharmacologically active principles and pharmaceutical compositions.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IQ23912 | 2012-08-30 | ||
| PCT/IB2013/058109 WO2014033654A1 (en) | 2012-08-30 | 2013-08-29 | Salts of benzothiazolone compound as beta-2-adrenoceptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA37872A1 true MA37872A1 (en) | 2018-07-31 |
Family
ID=53386469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA37872A MA37872A1 (en) | 2012-08-30 | 2013-08-29 | Benzothiazolone compound salts used as a beta-2-adrenoceptor agonist |
Country Status (27)
| Country | Link |
|---|---|
| EP (2) | EP3243817A1 (en) |
| KR (1) | KR20150047586A (en) |
| CN (2) | CN106146428A (en) |
| BR (1) | BR112015004127A2 (en) |
| CA (1) | CA2882877A1 (en) |
| CL (1) | CL2015000461A1 (en) |
| CY (1) | CY1120225T1 (en) |
| DK (1) | DK2890687T3 (en) |
| EA (1) | EA029946B1 (en) |
| ES (1) | ES2642003T3 (en) |
| HK (1) | HK1206015A1 (en) |
| HR (1) | HRP20171362T1 (en) |
| HU (1) | HUE033655T2 (en) |
| IL (1) | IL237382A0 (en) |
| LT (1) | LT2890687T (en) |
| MA (1) | MA37872A1 (en) |
| MX (1) | MX351741B (en) |
| MY (1) | MY169038A (en) |
| NZ (1) | NZ705319A (en) |
| PE (1) | PE20150465A1 (en) |
| PL (1) | PL2890687T3 (en) |
| PT (1) | PT2890687T (en) |
| SA (1) | SA515360076B1 (en) |
| SG (2) | SG11201501293PA (en) |
| SI (1) | SI2890687T1 (en) |
| TN (1) | TN2015000058A1 (en) |
| WO (1) | WO2014033654A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3192B1 (en) * | 2011-09-06 | 2018-03-08 | Novartis Ag | Benzothiazolone compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040962A1 (en) | 2002-08-09 | 2005-04-27 | Novartis Ag | COMPOUNDS DERIVED FROM TIAZOL 1,3-2-ONA, PHARMACEUTICAL COMPOSITION AND COMPOSITE PREPARATION PROCESS |
| CA2514733A1 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| WO2005110990A1 (en) | 2004-05-13 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases |
| GB0426164D0 (en) * | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| JO3192B1 (en) * | 2011-09-06 | 2018-03-08 | Novartis Ag | Benzothiazolone compound |
| PL2961391T3 (en) * | 2013-02-28 | 2017-10-31 | Novartis Ag | Formulation comprising benzothiazolone compound |
-
2013
- 2013-08-29 HU HUE13812075A patent/HUE033655T2/en unknown
- 2013-08-29 LT LTEP13812075.3T patent/LT2890687T/en unknown
- 2013-08-29 MX MX2015002656A patent/MX351741B/en active IP Right Grant
- 2013-08-29 CA CA2882877A patent/CA2882877A1/en not_active Abandoned
- 2013-08-29 EP EP17171708.5A patent/EP3243817A1/en not_active Withdrawn
- 2013-08-29 SI SI201330750T patent/SI2890687T1/en unknown
- 2013-08-29 NZ NZ705319A patent/NZ705319A/en not_active IP Right Cessation
- 2013-08-29 PT PT138120753T patent/PT2890687T/en unknown
- 2013-08-29 PL PL13812075T patent/PL2890687T3/en unknown
- 2013-08-29 MA MA37872A patent/MA37872A1/en unknown
- 2013-08-29 DK DK13812075.3T patent/DK2890687T3/en active
- 2013-08-29 EA EA201590452A patent/EA029946B1/en not_active IP Right Cessation
- 2013-08-29 SG SG11201501293PA patent/SG11201501293PA/en unknown
- 2013-08-29 WO PCT/IB2013/058109 patent/WO2014033654A1/en active Application Filing
- 2013-08-29 EP EP13812075.3A patent/EP2890687B1/en active Active
- 2013-08-29 PE PE2015000275A patent/PE20150465A1/en not_active Application Discontinuation
- 2013-08-29 KR KR1020157007573A patent/KR20150047586A/en not_active Application Discontinuation
- 2013-08-29 CN CN201610537241.9A patent/CN106146428A/en active Pending
- 2013-08-29 SG SG10201704377PA patent/SG10201704377PA/en unknown
- 2013-08-29 CN CN201380055093.1A patent/CN104736525B/en not_active Expired - Fee Related
- 2013-08-29 BR BR112015004127A patent/BR112015004127A2/en not_active Application Discontinuation
- 2013-08-29 MY MYPI2015000453A patent/MY169038A/en unknown
- 2013-08-29 ES ES13812075.3T patent/ES2642003T3/en active Active
-
2015
- 2015-02-20 TN TNP2015000058A patent/TN2015000058A1/en unknown
- 2015-02-23 IL IL237382A patent/IL237382A0/en unknown
- 2015-02-25 CL CL2015000461A patent/CL2015000461A1/en unknown
- 2015-02-26 SA SA515360076A patent/SA515360076B1/en unknown
- 2015-07-08 HK HK15106522.7A patent/HK1206015A1/en not_active IP Right Cessation
-
2017
- 2017-09-11 HR HRP20171362TT patent/HRP20171362T1/en unknown
- 2017-09-13 CY CY20171100967T patent/CY1120225T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2642003T3 (en) | 2017-11-14 |
| PE20150465A1 (en) | 2015-04-22 |
| BR112015004127A2 (en) | 2017-07-04 |
| LT2890687T (en) | 2017-09-11 |
| MY169038A (en) | 2019-02-07 |
| EA201590452A1 (en) | 2015-07-30 |
| SG11201501293PA (en) | 2015-03-30 |
| HK1206015A1 (en) | 2015-12-31 |
| WO2014033654A1 (en) | 2014-03-06 |
| CN104736525A (en) | 2015-06-24 |
| CN106146428A (en) | 2016-11-23 |
| CL2015000461A1 (en) | 2015-05-04 |
| PL2890687T3 (en) | 2017-11-30 |
| CA2882877A1 (en) | 2014-03-06 |
| HRP20171362T1 (en) | 2017-11-03 |
| EP2890687A1 (en) | 2015-07-08 |
| MX2015002656A (en) | 2015-05-20 |
| EP2890687B1 (en) | 2017-06-28 |
| IL237382A0 (en) | 2015-04-30 |
| DK2890687T3 (en) | 2017-10-09 |
| EP3243817A1 (en) | 2017-11-15 |
| PT2890687T (en) | 2017-10-05 |
| CN104736525B (en) | 2016-08-24 |
| NZ705319A (en) | 2018-05-25 |
| SA515360076B1 (en) | 2016-03-20 |
| SG10201704377PA (en) | 2017-06-29 |
| SI2890687T1 (en) | 2017-10-30 |
| HUE033655T2 (en) | 2017-12-28 |
| MX351741B (en) | 2017-10-26 |
| CY1120225T1 (en) | 2018-12-12 |
| KR20150047586A (en) | 2015-05-04 |
| EA029946B1 (en) | 2018-06-29 |
| TN2015000058A1 (en) | 2016-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124882T1 (en) | 1,4-DI-CONSTITUTED PYRIDAZINE ANALOGUES AND METHODS FOR THERAPEUTIC TREATMENT OF CONDITIONS RELATED TO SMN DEFICIENCY | |
| MA37477A1 (en) | Modulators of complement pathways and their uses | |
| MA37405A1 (en) | Heterocyclyl compounds | |
| MA34837B1 (en) | INDOLIC COMPOUNDS OR ANALOGS THEREFOR USEFUL IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) | |
| MA35275B1 (en) | Compounds of tetrahydropyridopyridine and tetrahydropyridopyrimidine and their use as c5a receptor modulators | |
| EA201592255A1 (en) | DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE | |
| MA33364B1 (en) | SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | |
| EA201592256A1 (en) | DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES | |
| MD20160078A2 (en) | Syk inhibitors | |
| MA35032B1 (en) | GLYCOSIDE DERIVATIVES AND THEIR USES IN THE TREATMENT OF DIABETES | |
| MA38330A1 (en) | Butanoic phosphonic acid derivatives of bisphenol substituted as nep inhibitors (neutral endopeptidase) | |
| EA201690247A1 (en) | AMINOMETHYBYRIL DERIVATIVES-INHIBITORS OF COMPLEX D FACTOR AND USE | |
| EA201492023A1 (en) | REGULATORS OF THE COMPLEX WAY AND THEIR APPLICATION | |
| PH12015502802A1 (en) | Formulation comprising a hypolipidemic agent | |
| MA39983A (en) | CARBOXAMIDE DERIVATIVES | |
| MX2021010046A (en) | A new therapeutical composition containing apomorphine as active ingredient. | |
| UA103329C2 (en) | Normal;heading 1;heading 2;heading 3;SALTS OF HIV INHIBITOR COMPOUNDS | |
| IN2014DN05972A (en) | ||
| EA201490573A1 (en) | CONTAINING BENZOTHIAZOLONE | |
| MA37872A1 (en) | Benzothiazolone compound salts used as a beta-2-adrenoceptor agonist | |
| EA201591487A1 (en) | DERIVATIVES OF SUBSTITUTED BISFENILBUTANIC ACID AS NEP INHIBITORS WITH IMPROVED IN VIVO EFFICIENCY | |
| IN2014MN02433A (en) | ||
| MA37879B1 (en) | Stabilized amorphous form of agomelatine, process for its preparation and pharmaceutical compositions containing it | |
| EA201490342A1 (en) | DERIVATIVES OF PYRAZOLINE AND THEIR APPLICATION AS A SELECTIVE MODULATOR OF THE ANDROGEN RECEPTOR | |
| MA34462B1 (en) | 2,3,5-TRISUBSTITUTED THIOPHENE COMPOUNDS AND USES THEREOF |